Cedars Sinai
Timothy Henry, MD, discusses the transformation of STEMI systems of care
In this issue, Timothy Henry, MD, MSCAI, director of the division of cardiology at Cedars-Sinai, talks with Cardiology Today about his roles in the early practice of interventional cardiology, the development of systems of care for STEMI and other emergency CV conditions and research in cell therapies for treatment of patients with HF or refractory angina.
Colonic release formulations of linaclotide show promise in IBS, other GI indications
NIH grants $10 million for Cedars-Sinai research in IBD genetics
For most cancer survivors, preventative CVD treatment, surveillance needed
LAS VEGAS — It is important for primary care doctors to understand the cardiovascular disease risks for cancer survivors and how to monitor those risks given that there are more than 13 million cancer survivors in the United States, according to a cardiologist here at the Cardiometabolic Risk Summit.
Pregnancy history can inform a woman's future risk of heart disease
Predictive overbooking improves endoscopy scheduling
CCFA pilot program increases urgent care access for patients with IBD
Lymphocytic thyroiditis yields high prevalence of benign cervical lymph nodes
Intraoperative digital radiography provided accurate component alignment in THA
Sentinel node biopsy noninferior to axillary lymph node dissection for node-positive breast cancer
CHICAGO — Long-term survival outcomes from the ACOSOG Z0011 trial supported the initial finding of noninferiority for sentinel node biopsy compared with axillary lymph node dissection in select patients with sentinel node–positive breast cancer, according to 10-year follow-up data presented at the ASCO Annual Meeting.